Federal funding for cancer research has led to significant advances in cancer prevention, detection, diagnosis, treatment, and quality of life of patients. More than 14.5 million cancer survivors are alive in the United States today, largely because of the nation’s commitment to cancer research.
Despite this progress, federal funding for cancer research has remained flat for more than a decade, and has decreased when adjusted for inflation.
- In inflation-adjusted dollars, the NIH budget was 23% lower in 2013 than it was a decade ago in 2003.
- Inadequate funding for federal research has led to fewer clinical trial options for cancer patients. Patient enrollment in NIH’s Clinical Trials Network dropped from 29,000 in 2009 to 20,000 in 2013.
ASCO is urging the federal government to take bold new action to ensure the pace of progress is not stalled. Sustained funding of the National Institutes of Health (NIH) and the National Cancer Institute (NCI) is critical to maintaining the pace of scientific discovery, continued progress against cancer, and the development and delivery of new cancer therapies for millions of current and future patients.
For More Information
- Federally Funded Cancer Research Educational Series
- Learn more about the 21st Century Cures Act in our "Accelerating Discovery in Cancer Care" section.
- Visit our Cancer Progress section to learn about the last 50 years of progress against cancer.
- To draw attention to this important topic, please use the Federally Funded Research Badge icon in your presentations. To learn more about using this graphic, please visit our information on downloading the Federally Funded Research Badge.